GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Opthea Ltd (NAS:OPT) » Definitions » 50-Day SMA

Opthea (Opthea) 50-Day SMA : $3.57 (As of May. 02, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Opthea 50-Day SMA?

Moving averages are one of the core indicators in technical analysis. A Simple Moving Average (SMA) is simply the arithmetic average of stock price over a period. It is calculated by adding a selected range of prices, usually closing prices, and then dividing that figure by the number of time periods in that range.

The 50-Day SMA calculates the average price over 50 days. And the 20-Day SMA and 200-Day SMA calculates the average price over 20 days and 200 days separately.

As of today (2024-05-02), Opthea's 50-Day SMA is $3.57. It's 20-Day SMA is $3.58 and 200-Day SMA is $2.72.


Competitive Comparison of Opthea's 50-Day SMA

For the Biotechnology subindustry, Opthea's 50-Day SMA, along with its competitors' market caps and 50-Day SMA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Opthea's 50-Day SMA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Opthea's 50-Day SMA distribution charts can be found below:

* The bar in red indicates where Opthea's 50-Day SMA falls into.



Opthea  (NAS:OPT) 50-Day SMA Calculation

The formula for calculating SMA is:

SMA=( P1 + P2 + ... + Pn ) / n

where:
Pn is the price of the stock at period n.
n is the total number of periods.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Opthea  (NAS:OPT) 50-Day SMA Explanation

Simple Moving Average (SMA) is the arithmetic average of stock price over a period. The 20-Day SMA calculates the average price over 20 days. And the 50-Day SMA and 200-Day SMA calculates the average price over 50 days and 200 days separately. SMAs are often used to determine the price trend direction. A 200-Day SMA is usually a proxy for the long-term trend, while shorter periods indicate short-term trend.

SMA are commonly compared with stock price or different period SMAs to indicate a trading signal. Generally speaking, if the price goes above the SMA, or a short-term SMA crosses above a long-term SMA, an uptrend is expected, investors may want to go long or cover short. Conversely, if the price goes below the SMA, or the short-term SMA crosses below a long-term SMA, a downtrend is expected, investors may want to go short or exit long.

Two popular trading patterns that use SMA include the death cross and a golden cross. A death cross occurs when the 50-day SMA crosses below the 200-day SMA. This is considered a bearish signal, that further losses are in store. The golden cross is a bullish signal which occurs when a short-term SMA crosses above a long-term SMA.


Opthea 50-Day SMA Related Terms

Thank you for viewing the detailed overview of Opthea's 50-Day SMA provided by GuruFocus.com. Please click on the following links to see related term pages.


Opthea (Opthea) Business Description

Traded in Other Exchanges
Address
650 Chapel Street, Level 4, Suite 0403, South Yarra, VIC, AUS, 3141
Opthea Ltd operates in one industry being the medical technology and healthcare. It is focused primarily on developing biological therapeutics for eye diseases. The company is developing a novel biologic therapy, OPT-302, for the treatment of eye diseases. Its products are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors C and D and R3 targets. Opthea's development activities are based on an intellectual property portfolio covering key targets Vascular Endothelial Growth Factors VEGF-C, VEGF-D and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage.

Opthea (Opthea) Headlines

From GuruFocus

Top 5 4th Quarter Trades of Regal Partners Ltd

By GuruFocus Research GuruFocus Editor 02-20-2023

Opthea To Present at Sequire Biotechnology Conference

By Stock market mentor Stock market mentor 01-30-2023

Opthea Presentation at The Retina World Congress 2022

By GuruFocusNews GuruFocusNews 06-29-2022

Opthea To Present at the JMP Securities Life Sciences Conference

By sperokesalga sperokesalga 05-08-2023

Opthea To Present at Upcoming Investor Conferences

By GuruFocusNews GuruFocusNews 06-20-2022

Opthea To Present at SVB Leerink Global Biopharma Conference

By Stock market mentor Stock market mentor 02-06-2023

Opthea to Present at the Jefferies 2023 Healthcare Conference

By sperokesalga sperokesalga 05-25-2023